Write For Us

Canadian lab investigating vaccine clotting

Sponsored Post Vitamin D2 Canada Persia
66 Views
Published
After the first confirmed case of a rare blood clot in Canada connected with the AstraZeneca COVID-19 vaccine, Dr. Ishac Nazy of the McMaster Platelet Immunology Laboratory in Hamilton says his team is working to identify a risk factor that can connect rare blood clots in certain people to a vaccine.
Read more: https://www.cbc.ca/1.5986097

»»» Subscribe to CBC News to watch more videos: http://bit.ly/1RreYWS

Connect with CBC News Online:

For breaking news, video, audio and in-depth coverage: http://bit.ly/1Z0m6iX
Find CBC News on Facebook: http://bit.ly/1WjG36m
Follow CBC News on Twitter: http://bit.ly/1sA5P9H
For breaking news on Twitter: http://bit.ly/1WjDyks
Follow CBC News on Instagram: http://bit.ly/1Z0iE7O
Subscribe to CBC News on Snapchat: https://bit.ly/3leaWsr

Download the CBC News app for iOS: http://apple.co/25mpsUz
Download the CBC News app for Android: http://bit.ly/1XxuozZ

»»»»»»»»»»»»»»»»»»
For more than 75 years, CBC News has been the source Canadians turn to, to keep them informed about their communities, their country and their world. Through regional and national programming on multiple platforms, including CBC Television, CBC News Network, CBC Radio, CBCNews.ca, mobile and on-demand, CBC News and its internationally recognized team of award-winning journalists deliver the breaking stories, the issues, the analyses and the personalities that matter to Canadians.
Category
World
Tags
blood clot, Astrazeneca, Johnson & Johnson
Sign in or sign up to post comments.
Be the first to comment